47 Ken Griffin Pfizer Trades
Ken Griffin acquired 7.03 Million Pfizer shares worth $163 Million. That's 0.16% of their equity portfolio (137th largest holding). The first Pfizer trade was made in Q2 2013. Since then Ken Griffin bought shares 64 more times and sold shares on 50 occasions. The investor's estimated purchase price is $234 Million, resulting in a loss of 30%.
Avg closing price
Price range
Sold 52.7% shares (-7.84 Million shares)
Q1 2025
Avg closing price
$26.17
Price range
$25.01
-
$27.13
Increased shares by 84.5% (+6.81 Million shares)
Q4 2024
Avg closing price
$27.11
Price range
$24.80
-
$30.19
Sold 60.5% shares (-12.3 Million shares)
Q3 2024
Avg closing price
$29.15
Price range
$27.70
-
$31.39
Increased shares by 63.0% (+7.89 Million shares)
Q2 2024
Avg closing price
$27.53
Price range
$25.26
-
$29.60
Increased shares by 7.6% (+879 Thousand shares)
Q1 2024
Avg closing price
$27.75
Price range
$25.89
-
$29.73
Increased shares by 408.5% (+9.34 Million shares)
Q4 2023
Avg closing price
$30.23
Price range
$26.13
-
$33.94
Increased shares by 7.6% (+162 Thousand shares)
Q3 2023
Avg closing price
$35.35
Price range
$32.09
-
$37.51
Increased shares by 39.4% (+601 Thousand shares)
Q2 2023
Avg closing price
$38.92
Price range
$36.12
-
$41.79
Increased shares by 27.7% (+331 Thousand shares)
Q1 2023
Avg closing price
$43.19
Price range
$39.39
-
$51.26
Sold 70.6% shares (-2.86 Million shares)
Q4 2022
Avg closing price
$47.94
Price range
$41.75
-
$54.48
Increased shares by 335.8% (+3.12 Million shares)
Q3 2022
Avg closing price
$48.59
Price range
$43.76
-
$53.42
Sold 34.9% shares (-499 Thousand shares)
Q2 2022
Avg closing price
$50.96
Price range
$46.53
-
$55.17
Increased shares by 45.5% (+447 Thousand shares)
Q1 2022
Avg closing price
$51.89
Price range
$45.75
-
$56.69
Sold 81.5% shares (-4.34 Million shares)
Q4 2021
Avg closing price
$49.55
Price range
$41.32
-
$61.25
Increased shares by 649.6% (+4.61 Million shares)
Q3 2021
Avg closing price
$44.30
Price range
$39.25
-
$50.42
Sold 91.3% shares (-7.45 Million shares)
Q2 2021
Avg closing price
$38.89
Price range
$35.91
-
$40.68
Increased shares by 593.0% (+6.98 Million shares)
Q1 2021
Avg closing price
$35.51
Price range
$33.49
-
$37.77
Increased shares by 0.3% (+3.69 Thousand shares)
Q3 2020
Avg closing price
$36.95
Price range
$33.46
-
$39.26
Sold 85.6% shares (-7 Million shares)
Q2 2020
Avg closing price
$35.81
Price range
$31.75
-
$38.51
Increased shares by 182.8% (+5.28 Million shares)
Q1 2020
Avg closing price
$35.91
Price range
$28.49
-
$40.71
News about Pfizer Inc. and Ken Griffin
Do Billionaires Israel Englander and Ken Griffin Know Something? Each Just Bought This Plagued Value Stock.
Hedge funds managed by Israel Englander and Ken Griffin both scooped up shares in a troubled pharmaceutical stock last quarter.
Billionaire Ken Griffin Just Bought 7.9 Million Shares of This Beaten-Down Pharmaceutical Stock as It Eyes the Weight Loss Market
Ken Griffin's Citadel continues to add to its position in Pfizer.